WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
SHANGHAI, China, July 10 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it was awarded one of the top 20 "China Most In...
WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy
SHANGHAI, China, July 10 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has appointed Dr. Debra Yu as the Vice Presi...
WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
SHANGHAI, China, July 2 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has appointed Mr. Bob Zhu as Vice President...
WuXi PharmaTech 2007 Annual Report Available Online
SHANGHAI, China, June 19 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has posted its 2007 annual rep...
WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
SHANGHAI, China, June 10 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that it has signed a new three-year collaboration ag...
WuXi PharmaTech Announces First Quarter 2008 Results
First Quarter Revenues Up 69% and Net Income Up 132% Year-Over-Year SHANGHAI, China, May 28 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the...
WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology
SHANGHAI, China, May 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today proudly announced that it has appointed Dr. Peng Wang as Vi...
The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
SHANGHAI, China, May 21 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that it has acquired a QPatch HT automated patch clam...
Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
SHANGHAI, China, May 21 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that the distinguished Stanford University Pro...
WuXi PharmaTech Schedules First Quarter 2008 Earnings Release on Tuesday, May 27, 2008
Earnings Conference Call to be held on May 28, 2008 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Hong Kong) SHANGHAI, China, May 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and developm...
WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
SHANGHAI, China, May 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that it has postponed its proposed und...
WuXi PharmaTech (NYSE: WX) Endows a New Faculty Position at Tongji University
SHANGHAI, China, April 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it endowed a new professor position...
WX Crowned 'Chemistry CRO of the Year' by Pfizer
SHANGHAI, China, April 7, 2008 /Xinhua-PRNewswire-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it was awarded the 2...
WuXi PharmaTech (Cayman) Inc. Announces Filing of Registration Statement For Follow-On and Secondary Offering
SHANGHAI, China, April 7, 2008 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech"), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it ha...
Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
SHANGHAI, China, March 31 /Xinhua-PRNewswire/ -- WuXi PharmaTech, the leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, was very honored to have Professor David W. C. MacMillan, a renowned researcher from Princeton Un...
WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results
Full Year Net Revenues up 93.3%; Full Year Net Income up 283.0% SHANGHAI, China, March 13 /Xinhua-PRNewswire-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), the leading global pharmaceutical, biotechnology and medical device R&D outsourcing company headquartered in Shanghai, China, to...
WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, March 12, 2008
Earnings Conference Call to be held on March 13, 2008 at 9:00 am (Eastern) / 6:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong) SHANGHAI, China, Feb. 21 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) ("WuXi PharmaTech" or "the Company"), the leading China-based pharmaceutical ...
WuXi PharmaTech (NYSE: WX) Its Service Creed "We Are Determined to Serve You Better" is Officially Registered
SHANGHAI, China, Feb. 7 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China's premier provider of pharmaceutical R&D outsourcing services is pleased to announce today that the company has received the original United States Certificate of Registration from the U.S. Patent and Trademark Of...
WuXi PharmaTech Completes Acquisition of AppTec
SHANGHAI, China, Feb. 1 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX) today announced the completion of its acquisition of AppTec Laboratory Services, Inc., a US-based service provider for the biopharmaceutical and medical device industries. AppTec offers testing, contract research and devel...
WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit Committee
SHANGHAI, China, Jan. 7 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), China’s premier provider of pharmaceutical R&D outsourcing services, announced today that Mr. Cuong Viet Do will temporarily assume the role of the Chairman of the Audit Committee until a permanent successor is appointed....
